Jones Financial Companies
GILD icon

Jones Financial Companies’s Gilead Sciences GILD Stock Holding History

Jones Financial Companies’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$64.3M Buy
502,809
+19,576
+4% +$2.58M 0.03% 338
2026
Q1 		$64.9M Buy
483,233
+395,026
+448% +$55.3M 0.03% 288
2025
Q4 		$10.8M Buy
88,207
+8,404
+11% +$1.02M 0.01% 430
2025
Q3 		$8.94M Buy
79,803
+7,144
+10% +$812K 0.01% 430
2025
Q2 		$8.04M Buy
72,659
+8,926
+14% +$950K 0.01% 398
2025
Q1 		$7.12M Buy
63,733
+11,929
+23% +$1.23M 0.01% 361
2024
Q4 		$4.79M Buy
51,804
+15,263
+42% +$1.37M ﹤0.01% 367
2024
Q3 		$3.06M Buy
36,541
+15,389
+73% +$1.17M ﹤0.01% 370
2024
Q2 		$1.45M Buy
21,152
+15,133
+251% +$1.01M ﹤0.01% 370
2024
Q1 		$441K Buy
6,019
+4,572
+316% +$352K ﹤0.01% 346
2023
Q4 		$117K Buy
1,447
+519
+56% +$40.4K ﹤0.01% 387
2023
Q3 		$69.5K Hold
928
– – ﹤0.01% 337
2023
Q2 		$71.5K Sell
928
-113
-11% -$9.01K ﹤0.01% 337
2023
Q1 		$86.4K Buy
1,041
+331
+47% +$27.4K ﹤0.01% 315
2022
Q4 		$61K Buy
710
+66
+10% +$5.23K ﹤0.01% 332
2022
Q3 		$40K Hold
644
– – ﹤0.01% 339
2022
Q2 		$40K Hold
644
– – ﹤0.01% 346
2022
Q1 		$38K Sell
644
-381
-37% -$24.4K ﹤0.01% 375
2021
Q4 		$74K Hold
1,025
– – ﹤0.01% 327
2021
Q3 		$72K Sell
1,025
-44
-4% -$3.09K ﹤0.01% 294
2021
Q2 		$74K Sell
1,069
-1,144
-52% -$76.4K ﹤0.01% 285
2021
Q1 		$143K Buy
2,213
+886
+67% +$57.1K ﹤0.01% 249
2020
Q4 		$77K Buy
+1,327
New +$80.1K ﹤0.01% 265
2013
Q4 		– Sell
-565
Closed -$36K – 358
2013
Q3 		$36K Sell
565
-161
-22% -$9.62K ﹤0.01% 342
2013
Q2 		$37K Buy
+726
New +$37.8K ﹤0.01% 354

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jones Financial Companies's GILD Position: Q2 2026 in Review

Jones Financial Companies increased its Gilead Sciences (GILD) stake by 4.1% in Q2 2026, buying an estimated $2.58M and bringing the position to 502,809 shares worth $64.3M. The position accounts for 0.03% of the portfolio, ranked #338.

Jones Financial Companies first reported a position in GILD in Q2 2013 and has held it in 25 quarters since. The position peaked at $64.9M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Jones Financial Companies held 502,809 shares of Gilead Sciences worth $64.3M as of Q2 2026.
  • Jones Financial Companies bought 19,576 Gilead Sciences shares in Q2 2026, an estimated $2.58M.
  • Gilead Sciences made up 0.03% of Jones Financial Companies's portfolio in Q2 2026, its #338 holding.
  • Jones Financial Companies first reported a position in Gilead Sciences in Q2 2013 and has held it in 25 quarters since.
  • Jones Financial Companies's Gilead Sciences position peaked at $64.9M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.